Fuller & Thaler Asset Management’s AngioDynamics ANGO Stock Holding History

Fuller & Thaler Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,905	Closed	-$79K	–	481
2019 Q4	$79K	Buy	4,905 +270	+6%	+$4.12K	﹤0.01%	393
2019 Q3	$85K	Hold	4,635	–	–	﹤0.01%	396
2019 Q2	$91K	Hold	4,635	–	–	﹤0.01%	390
2019 Q1	$106K	Buy	4,635 +2,040	+79%	+$44.3K	﹤0.01%	375
2018 Q4	$52K	Buy	2,595 +2,025	+355%	+$41.9K	﹤0.01%	381
2018 Q3	$12K	Hold	570	–	–	﹤0.01%	432
2018 Q2	$13K	Hold	570	–	–	﹤0.01%	740
2018 Q1	$10K	Buy	570 +45	+9%	+$751	﹤0.01%	742
2017 Q4	$9K	Buy	+525	New	+$8.96K	﹤0.01%	713

Other funds holding ANGO

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Fuller & Thaler Asset Management's ANGO Position: Q1 2020 in Review

Fuller & Thaler Asset Management sold out of AngioDynamics (ANGO) in Q1 2020, closing a stake of 4,905 shares — an estimated $79K sold.

Fuller & Thaler Asset Management first reported a position in ANGO in Q4 2017 and held it in 9 quarters. The position peaked at $106K in Q1 2019. 158 funds tracked by Wall St. Rank hold ANGO as of Q1 2020.

Fuller & Thaler Asset Management reported no remaining AngioDynamics position as of Q1 2020 after selling out during the quarter.
Fuller & Thaler Asset Management sold 4,905 AngioDynamics shares in Q1 2020, an estimated $79K.
Fuller & Thaler Asset Management first reported a position in AngioDynamics in Q4 2017 and held it in 9 quarters.
Fuller & Thaler Asset Management's AngioDynamics position peaked at $106K in Q1 2019.
158 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2020.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2020, filed 6 May 2020.